---
title: "This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284215416.md"
description: "Top Wall Street analysts have initiated coverage on several companies with bullish ratings. Stephen Richardson from Evercore ISI rated HMH Holding Inc (NASDAQ:HMH) as Outperform with a price target of $27. Raghuram Selvaraju from HC Wainwright rated LB Pharmaceuticals Inc (NASDAQ:LBRX) as Buy with a target of $45. Allen Lutz from B of A Securities rated Guardian Pharmacy Services Inc (NYSE:GRDN) as Buy with a target of $42. Selvaraju also rated NervGen Pharma Corp (NASDAQ:NGEN) as Buy with a target of $18. HMH shares closed at $20.13, LBRX at $30.73, GRDN at $37.57, and NGEN at $3.92 on Friday."
datetime: "2026-04-27T12:08:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284215416.md)
  - [en](https://longbridge.com/en/news/284215416.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284215416.md)
---

# This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Evercore ISI Group analyst Stephen Richardson initiated coverage on **HMH Holding Inc** (NASDAQ:HMH) with an Outperform rating and announced a price target of $27. HMH Holding shares closed at $20.13 on Friday. See how other analysts view this stock.
-   HC Wainwright & Co. analyst Raghuram Selvaraju initiated coverage on **LB Pharmaceuticals Inc** (NASDAQ:LBRX) with a Buy rating and announced a price target of $45. LB Pharmaceuticals shares closed at $30.73 on Friday. See how other analysts view this stock.
-   B of A Securities analyst Allen Lutz initiated coverage on **Guardian Pharmacy Services Inc** (NYSE:GRDN) with a Buy rating and announced a price target of $42. Guardian Pharmacy shares closed at $37.57 on Friday. See how other analysts view this stock.
-   HC Wainwright & Co. analyst Raghuram Selvaraju initiated coverage on **NervGen Pharma Corp** (NASDAQ:NGEN) with a Buy rating and announced a price target of $18. NervGen Pharma shares closed at $3.92 on Friday. See how other analysts view this stock.
-   Stifel analyst Stephen Gengaro initiated coverage on **HMH Holding Inc** (NASDAQ:HMH) with a Buy rating and announced a price target of $27. HMH Holding shares closed at $20.13 on Friday. See how other analysts view this stock.

Considering buying LBRX stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [LBRX.US](https://longbridge.com/en/quote/LBRX.US.md)
- [HMH.US](https://longbridge.com/en/quote/HMH.US.md)
- [GRDN.US](https://longbridge.com/en/quote/GRDN.US.md)
- [NGEN.US](https://longbridge.com/en/quote/NGEN.US.md)

## Related News & Research

- [Craig-Hallum Keeps Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)](https://longbridge.com/en/news/286273988.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Earnings Beat: Odfjell Drilling Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286515920.md)
- [LifeSci Capital Sticks to Their Buy Rating for Olema Pharmaceuticals (OLMA)](https://longbridge.com/en/news/286679129.md)